http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3a9673121282c95f08409fa35476a01b
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Madin |
| name | Andrew Madin |
| given-name | Andrew |
| organization-name | Discovery Sciences IMED Biotech Unit, AstraZeneca, 310 Cambridge Science Park, Milton Road, Cambridge CB4 0WG, U.K. Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 OWG, U.K. Departments of Medicinal Chemistry, Molecular and Cellular Neuroscience, and in Vivo Neuroscience, The Neuroscience Research Centre, Merck Sharp & Dohme Research Laboratories, Terlings Park, Eastwick Road, Harlow, Essex, CM20 2QR, U.K., and Department of Process Research, Merck Research Laboratories, 126 East Lincoln Avenue, Rahway, New Jersey 07065 AstraZeneca UK Ltd. 310 Cambridge Science Park, Milton Rd Cambridge CB4 0FZ UK Contribution from the Department of Chemistry, University of California, Irvine, 516 Rowland Hall, Irvine, California 92697-2025 Charles River Laboratories, 8-9 Spire Green, Flex Meadow, Harlow, Essex CM19 5TR, United Kingdom AstraZeneca, Cambridge CB2 0AA, U.K. Hit Discovery; Discovery Sciences; R&D; AstraZeneca; Cambridge AstraZeneca (UK) Ltd. 310 Cambridge Science Park, Milton Rd Cambridge CB4 0FZ UK Departments of Medicinal Chemistry, Biochemistry, and Pharmacology, Merck Sharp and Dohme Research Laboratories, Neuroscience Research Centre, Terlings Park, Eastwick Road, Harlow, Essex CM20 2QR, U.K. Authors' Affiliations: 1Novartis Pharma AG, Basel, Switzerland; 2Astex Therapeutics Ltd., Cambridge, United Kingdom; 3Ortho Biotech Oncology R&D, Beerse, Belgium; and 4Newcastle Cancer Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom Hit Discovery, Discovery Sciences, R&D, AstraZeneca, Cambridge, U.K. Hit Discovery, Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K. Hit Discovery, Discovery Sciences, IMED Biotech Unit, AstraZeneca, Cambridge CB4 0WG, U.K. |
Incoming Links
Total number of triples: 44.